Amgen (AMGN) FCF Margin (2009 - 2026)

Amgen's FCF Margin history runs 18 years deep, the most recent figure standing at 17.14% for Q1 2026.

• In Q1 2026, FCF Margin rose 511.0% year-over-year to 17.14%; the TTM figure through Mar 2026 stood at 23.1% (down 889.0% YoY), while the FY2025 annual figure was 22.04%, down 906.0% from the prior year.
• FCF Margin was 17.14% for Q1 2026 at Amgen, up from 9.74% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 503.05% in Q4 2022 to a low of 3.53% in Q4 2023.
• Historically, FCF Margin has averaged 54.91% across 5 years, with a median of 26.48% in 2024.
• The sharpest annual moves came in 2022 and 2023: FCF Margin jumped 46623 bps in 2022, then plunged 49952 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 503.05% in 2022, then sank by 99 bps to 3.53% in 2023, then soared by 1273 bps to 48.43% in 2024, then plunged by 80 bps to 9.74% in 2025, then soared by 76 bps to 17.14% in 2026.
• The last three FCF Margin figures came in at 17.14% (Q1 2026), 9.74% (Q4 2025), and 44.45% (Q3 2025), per Business Quant data.